Pratt, Christopher P.
1787  Ergebnisse:
?
2

CNTNAP2 is targeted to endosomes by the polarity protein PA..:

Gao, Ruoqi ; Pratt, Christopher P. ; Yoon, Sehyoun...
European Journal of Neuroscience.  51 (2019)  4 - p. 1074-1086 , 2019
 
?
9

Genome-wide association meta-analysis identifies 48 risk va..:

Trpchevska, Natalia ; Freidin, Maxim B ; Broer, Linda...
Trpchevska , N , Freidin , M B , Broer , L , Oosterloo , B C , Yao , S , Zhou , Y , Vona , B , Bishop , C , Bizaki-vallaskangas , A , Canlon , B , Castellana , F , Chasman , D I , Cherny , S , Christensen , K , Concas , M P , Correa , A , Elkon , R , Mengel-from , J , Gao , Y , Giersch , A B S , Girotto , G , Gudjonsson , A , Gudnason , V , Heard-costa , N L , Hertzano , R , Hjelmborg , J V B , Hjerling-leffler , J , Hoffman , H J , Kaprio , J , Kettunen , J , Krebs , K , Kähler , A K , Lallemend , F , Launer , L J , Lee , I , Leonard , H , Li , C , Lowenheim , H , Magnusson , P K E , Van Meurs , J , Milani , L , Morton , C C , Mäkitie , A , Nalls , M A , Nardone , G G , Nygaard , M , Palviainen , T , Pratt , S , Quaranta , N , Rämö , J , Saarentaus , E , Sardone , R , Satizabal , C L , Schweinfurth , J M , Seshadri , S , Shiroma , E , Shulman , E , Simonsick , E , Spankovich , C , Tropitzsch , A , Lauschke , V M , Sullivan , P F , Goedegebure , A , Ced....  , 2022
 
?
10

Arthritis prevention in the pre-clinical phase of RA with a..:

Al-Laith, Mariam ; Jasenecova, Marianna ; Abraham, Sonya...
Al-Laith , M , Jasenecova , M , Abraham , S , Bosworth , A , Bruce , I N , Buckley , C D , Ciurtin , C , D'Agostino , M A , Emery , P , Gaston , H , Isaacs , J D , Filer , A , Fisher , B A , Huizinga , T W J , Ho , P , Jacklin , C , Lempp , H , McInnes , I B , Pratt , A G , Östor , A , Raza , K , Taylor , P C , Van Schaardenburg , D , Shivapatham , D , Wright , A J , Vasconcelos , J C , Kelly , J , Murphy , C , Prevost , A T & Cope , A P 2019 , ' Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study) : A multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol ' , Trials , vol. 20 , no. 1 , 429 . https://doi.org/10.1186/s13063-019-3403-7.  , 2019
 
?
11

Arthritis prevention in the pre-clinical phase of RA with a..:

Al-Laith, Mariam ; Jasenecova, Marianna ; Abraham, Sonya...
Al-Laith , M , Jasenecova , M , Abraham , S , Bosworth , A , Bruce , I N , Buckley , C D , Ciurtin , C , D'Agostino , M A , Emery , P , Gaston , H , Isaacs , J D , Filer , A , Fisher , B A , Huizinga , T W J , Ho , P , Jacklin , C , Lempp , H , McInnes , I B , Pratt , A G , Östor , A , Raza , K , Taylor , P C , Van Schaardenburg , D , Shivapatham , D , Wright , A J , Vasconcelos , J C , Kelly , J , Murphy , C , Prevost , A T & Cope , A P 2019 , ' Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study) : A multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol ' , Trials , vol. 20 , no. 1 , 429 . https://doi.org/10.1186/s13063-019-3403-7.  , 2019
 
?
 
1-15